Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem - Concepedia

Concepedia

Publication | Closed Access

Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem

17

Citations

33

References

2005

Year

Takehito Yamamoto, Takahiro Kubota, Takeshi Ozeki, Mika Sawada, Shin‐ichi Yokota, Yasuhiko Yamada, Yuji Kumagai, Tatsuji Iga

Clinica Chimica Acta

MedicineGeneticsCyp3a5 Genetic PolymorphismPharmacogenomicsPharmacotherapyPharmacologyPharmacokineticsDrug Resistance

References

	Year	Citations

Page 1